Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma
- 28 June 2005
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 5 (10), 2631-2640
- https://doi.org/10.1002/pmic.200401264
Abstract
Renal cell carcinoma (RCC) representing the most common neoplasia of the kidney in Western countries is a histologic diverse disease with an often unpredictable course. The prognosis of RCC is worsened with the onset of metastasis, and the therapies currently available are of limited success for the treatment of metastatic RCC. Although gene expression analyses and other methods are promising tools clarifying and standardizing the pathological classification of RCC, novel innovative molecular markers for the diagnosis, prognosis, and for the monitoring of this disease during therapy as well as potential therapeutic targets are urgently needed. Using proteome‐based strategies, a number of RCC‐associated markers either over‐expressed or down‐regulated in tumor lesions in comparison to the normal epithelium have been identified which have been implicated in tumorigenesis, but never linked to the initiation and/or progression of RCC. These include members of the fatty acid binding protein family, which have the potential to serve as diagnostic or prognostic markers for the screening of RCC patients.Keywords
This publication has 42 references indexed in Scilit:
- Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell CancerCancer Research, 2004
- Therapeutic Options for Variant Renal CancerClinical Cancer Research, 2004
- Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseasesNeuroscience Letters, 2004
- Brain- and Heart-Type Fatty Acid-Binding Proteins in the Brain: Tissue Distribution and Clinical UtilityClinical Chemistry, 2004
- Expression of heat shock protein 27 in human renal cell carcinomaProteomics, 2004
- Liver-Type Fatty Acid-Binding Protein Is Highly Expressed in Intestinal Metaplasia and in a Subset of Carcinomas of the Stomach without Association with the Fatty Acid Synthase Status in the CarcinomaPathobiology, 2004
- Down-Regulation of HLA Class I Antigen Processing Molecules: An Immune Escape Mechanism of Renal Cell Carcinoma?Journal of Urology, 2004
- Identification of markers for the selection of patients undergoing renal cell carcinoma‐specific immunotherapyProteomics, 2003
- Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinomaProteomics, 2003
- Immunohistochemical demonstration of liver fatty acid‐binding protein in human hepatocellular malignanciesThe Journal of Pathology, 1990